George Q Daley

USPTO Granted Patents = 18 (Patent Applications = 16)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 266(Granted Patents)

Location History:

Weston, MA (US) (2001 - 2022)
Cambridge, MA (US) (2022 - 2024)

Company Filing History:

14 out of 1,039

Children's Medical Center Corporation

Whitehead Institute for Biomedical Research

patents

4. 1 out of 1,386

The Brigham and Women's Hospital, Inc.

patents

5. 3 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12146162 - Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer (2024-11-19),

2. 11980620 - Compounds and methods for treatment of Diamond Blackfan anemia (2024-05-14),

3. 11572544 - Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer (2023-02-07),

4. 11525119 - Immune cells derived from induced pluripotent stem cell (2022-12-13),

5. 11512316 - Enhanced organogenesis through manipulation of LIN28/LET-7/DIS3L2 (2022-11-29),

6. 11261430 - Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells (2022-03-01),

7. 11162073 - Methods for generating functional hematopoietic stem cells (2021-11-02),

8. 9846164 - Detection of human somatic cell reprogramming (2017-12-19),

9. 9670463 - Inhibition and enhancement of reprogramming by chromatin modifying enzymes (2017-06-06),

10. 8703413 - Detection of human somatic cell reprogramming (2014-04-22),

11. 8546382 - Methods for enhancing hematopoietic progenitor cell engraftment (2013-10-01),

12. 8283331 - Methods to regulate miRNA processing by targeting Lin-28 (2012-10-09),

13. 8101412 - Method of enhancing proliferation and/or hematopoietic differentiation of stem cells (2012-01-24),

14. 7427603 - Method of enhancing proliferation and/or hematopoietic differentiation of stem cells (2008-09-23),

15. 6777415 - Methods of inducing cancer cell death and tumor regression (2004-08-17),

Title: **Innovative Contributions of George Q Daley in Stem Cell Research**

Introduction

George Q Daley is a prominent inventor based in Weston, MA, who has significantly advanced the field of stem cell research. With an impressive portfolio of 18 patents, his work focuses on developing novel methods and treatments for various hematological conditions.

Latest Patents

Among his latest patents are groundbreaking inventions that aim to revolutionize hematopoietic stem cell (HSC) therapies. One such patent details:

1. **Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer**: This patent outlines in vitro production methods for HSCs and hematopoietic stem and progenitor cells (HSPCs). The cells exhibit long-term multilineage hematopoiesis potential upon in vivo engraftment. The derivation from pluripotent stem cell-derived hemogenic endothelial cells through non-integrative episomal vectors is a crucial innovation in the field.

2. **Compounds and methods for treatment of Diamond Blackfan anemia**: This invention pertains to strategies for treating ribosomal disorders, particularly Diamond Blackfan anemia (DBA). The focus is on methods utilizing small-molecule autophagy modulators, emphasizing drug discovery and screening for effective treatments for ribosomal disorders.

Career Highlights

Throughout his career, George Q Daley has held significant positions in various research institutions, such as the Children's Medical Center Corporation. His work has not only contributed to academic knowledge but has also had practical implications in treatment methodologies.

Collaborations

Daley has collaborated with several esteemed professionals in the field, including notable figures like Eric Lander and Michele Cargill. Their joint efforts have fostered innovative solutions and advanced the understanding of stem cell biology.

Conclusion

George Q Daley exemplifies the essence of innovation within the realm of stem cell research. His groundbreaking patents contribute to significant advancements in medical science, offering hope for improved treatment options for hematological disorders. His collaborations and career achievements reflect a profound commitment to enhancing our understanding and application of stem cell technologies.

This text is generated by artificial intelligence and may not be accurate.